The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 62 sources its claims cite is checked for support yet.
Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters
Open accessAbstract
Background: The cannabinoid receptor 2 (CB 2 ) is involved in regulating immune responses, yet its specific function in microglia remains poorly defined. This study aimed to generate and validate a microglia-specific, inducible CB 2 knockout mouse model incorporating reporter genes to enable precise detection of CB 2 expression and CB 2 knockout. Methods: A novel floxed CB 2 mouse line was generated, incorporating GFP and tdTomato reporter genes driven by the Cnr2 promoter to indicate CB 2 expression and CB 2 knockout, respectively. This line was crossed with Cx3cr1 or Tmem119 tamoxifen-inducible Cre lines to achieve macrophage- or microglia-specific CB 2 knockout, respectively. Behavioural testing, in vitro assays, sequencing and in vivo immunofluorescence were used to assess the efficiency and specificity of CB 2 knockout as well as potential off-target effects. Results: The floxed allele did not alter breeding or motor behaviour in mice, nor CB 2 function. CB 2 expression, indicated by GFP, followed expected patterns across tissues and conditions. Sequencing revealed both DNA and RNA of the floxed allele was as anticipated. Tamoxifen-induced Cre activity successfully initiated tdTomato expression exclusively in microglia of tamoxifen treated, Cre positive mice, validating the specificity and inducibility of CB 2 knockout. Microglial tdTomato expression confirmed successful CB 2 knockout in 9.3% of TmemCB 2 and 91.7% of Cx3CB 2 microglia. Peripheral tdTomato expression persisted beyond 3 weeks post-tamoxifen in Cx3CB 2 mice but was minimal in TmemCB 2 mice. Conclusion: This novel microglia-specific, inducible CB 2 knockout model is the first to combine a floxed CB 2 allele with reporter genes, an essential advancement given the lack of reliable CB 2 antibodies. The findings demonstrate the model’s specificity and effectiveness, while highlighting important considerations regarding Cre-mediated effects and recombination specificity. Furthermore, the floxed mouse can be crossed with any Cre line to study CB 2 expression and function in various tissues. This model provides a powerful platform for advancing understanding of CB 2 roles in microglia and supports future exploration of CB 2 -targeted therapeutic strategies.
Checked 2026-11-19 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
The authors generated and validated a novel floxed Cnr2 (CB2) mouse line in which GFP reports CB2 promoter activity and a Cre-dependent FLEx-switched tdTomato permanently marks cells that have undergone CB2 knockout. Crossed to Cx3cr1- or Tmem119-driven tamoxifen-inducible Cre lines, the model produced microglia-specific recombination without altering breeding, motor behaviour, or CB2 signalling, though peripheral recombination persisted beyond 3 weeks in the Cx3CB2 line.
Key findings
- The floxed allele was functionally neutral: no differences from BL6 controls in litter size (F(3, 196) = 1.31, p = 0.27), mortality (KW(4, 200) = 3.79, p = 0.28), sex ratio (F(3, 192) = 0.094, p = 0.96), open-field distance (t(11) = 0.670, p = 0.516), or rotarod latency to fall (t(11) = 0.346, p = 0.736). Hu308-induced cAMP inhibition was equivalent across CB2flx, Cx3CB2, and BL6 in microglia (F(2,28) = 0.027, p = 0.973) and astrocytes (F(2,32) = 0.432, p = 0.653).
- GFP expression matched expected CB2 distribution: minimal in naive CNS, strong in spleen white pulp, and markedly upregulated in the CNS after intrastriatal LPS.
- Tamoxifen-induced tdTomato was microglia-specific and Cre-dependent, confirming CB2 knockout in 9.3% of TmemCB2 microglia (F(3, 8) = 18.23, p = 0.0006) and 91.7% of Cx3CB2 microglia; 94.3% of tdT signal colocalized with Iba1 in TmemCB2 mice, and >92% in Cx3CB2 mice, with no significant differences among the three tamoxifen protocols (F(2, 7) = 4.07, p = 0.067).
- Peripheral tdT persisted in Cx3CB2 spleens beyond 3 weeks post-tamoxifen, contradicting the assumption that this washout yields microglia-restricted recombination; TmemCB2 spleens showed only rare tdT.
Methods
- Generation of the C57BL/6-Cnr2 tm1(GFP,tdTomato)BViss/J (CB2flx) line: the entire Cnr2 coding region flanked by loxP sites, with GFP in sense orientation and a tdTomato cassette in inverse orientation flanked by lox2272 sites (FLEx switch), both under the Cnr2 promoter; crossed to Cx3cr1-Cre/ERT2 (Cx3CB2) and Tmem119-Cre/ERT2 (TmemCB2) lines.
- Validation battery: DNA and mRNA sequencing (OzGene; Garvan Genetics Core), breeding outcome analysis (50 litters per strain), open-field and accelerating rotarod testing, primary glial cAMP assays with the CB2 agonist Hu308, and immunofluorescence colocalization (GFP, tdT, Iba1, CD68, GFAP, NeuN) quantified in FIJI with the Colocalization Object Counter plugin.
- Tamoxifen regimens compared: 150 mg/kg every other day ×4, 100 mg/kg daily ×8, or 100 mg/kg twice daily ×10; tissue collected 3 weeks after the final injection. Neuroinflammation was induced by stereotaxic intrastriatal LPS (5 mg/mL, two 1 µL injections) with histology 15 days post-surgery. Statistics used Prism 10 with ANOVA and Tukey's, Dunnett's, Dunn's, or Šídák's post hoc tests.
Limitations
- Stated: tdT is only expressed when the Cnr2 promoter is active, so because basal CNS CB2 expression is very low, most knockout cells would not be expected to express tdT — the authors note DNA-based methods such as in situ hybridisation are needed for definitive KO efficiency confirmation.
- Stated: in Cx3CB2 Cre/+ microglia, overlapping GFP and YFP emission spectra could not be distinguished, preventing direct assessment of CB2-driven GFP in those cells; a 510 bp stretch of the 5′ homology arm yielded incomplete DNA sequencing data due to poor trace quality (though the low-quality region showed 100% identity to the predicted sequence).
- Stated: tdT expression exceeded GFP expression in controls despite both being driven by the Cnr2 promoter, which the authors attribute speculatively to Cre toxicity — a hypothesis they explicitly say requires further research; they also note Tmem119 is downregulated in activated microglia and that 3 weeks is insufficient for peripheral clearance in the Cx3CB2 line, requiring a time-course study. Evident from the text: colocalization quantification used small group sizes (N = 3–4 per group).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
0 Valid · 3 Not valid · 31 Not checked · 134 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant difference between groups for litter size (F (3, 196) = 1.31, p = 0.27; Figure 2A)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mortality rate (KW(4, 200) = 3.79, p = 0.28; Figure 2B)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conversely, tdT was detected in Cx3CB2 Cre/+ spleens 1-week post-Tam, as anticipated (Supplementary Figure S6B).”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Tam induces microglial specific tdT expression in Cx3CB2 mice
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Microglial tdTomato expression confirmed successful CB2 knockout in 9.3% of TmemCB2 and 91.7% of Cx3CB2 microglia.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Abstract > Results
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the absence of Cre recombinase, CB2 and GFP are expressed under the control of the Cnr2 promoter.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Methods > Animals
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
120 more claims
Create a free account to see all 168 claims and to verify the 51 references still open.
- The quote only partly states this claim. 1
- It may state two separate claims as one. 25
- Probably not a substantial claim. 21
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(3, 196) = 1.31reported p = .27 · recomputed p = .272
“F (3, 196) = 1.31, p = .27”
- ConsistentF(3, 192) = 0.094reported p = .96 · recomputed p = .963
“F (3, 192) = 0.094, p = .96”
- Consistentt(11) = 0.67reported p = .516 · recomputed p = .517
“t (11) = 0.670, p = .516”
- Consistentt(11) = 0.421reported p = .682 · recomputed p = .682
“t (11) = 0.421, p = .682”
- Consistentt(11) = 1.138reported p = .279 · recomputed p = .279
“t (11) = 1.138, p = .279”
8 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Discussion
“Importantly, tdT expression was exclusively observed in microglia of Cre/+ mice following Tam administration, validating the inducibility and specificity of the Cre-lox system.”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Tamoxifen induced reporter gene expression in the TmemCB2 line
“However, rare tdT expression was detected in the spleen of Tam-treated TmemCB2 Cre/+ mice (Figures 9C,D), though at significantly lower levels than in Cx3CB2 mice.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
“mortality rate (KW(4, 200) = 3.79, p = 0.28; Figure 2B)”
§ Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters > Results > Genetic modifications do not impair reproductive fitness
“(B) Proportion of litter mortality between birth and weaning. One-way ANOVA, Dunnett’s post hoc test.”
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Microglia states and nomenclature: A field at its crossroads
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.020 · Cited by 1,973
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525
Structure and function of the immune system in the spleen
Lewis, S. M., Williams, A., & Eisenbarth, S. C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6085 · Cited by 1,301
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Cited by
Moliterni, C., Caissutti, D., Mandolini, E., Fasciolo, E., Çağlar, T. R., Capozzi, A., Misasi, R., & Candelise, N. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1882543 · Cited by 1
Peralta, J. J. A., Fernández, A. M. M., & López, J. F. M. (2026) · Zaguan (University of Zaragoza Repository)
dos Santos, B. C., da Rosa, I. V., MAZZARDO, L. D. F., Santos, N. D. S., Fabro, I. F., Nery, T., Bastos-Pereira, A. L., & Aguiar, A. S. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00206
Metadata
- Authors
- Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B.
- Affiliations
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- Corresponding author
- Vissel, Bryce
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2025-11-19
- Volume
- 16
- Pages
- 1682979-1682979
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC12672438
- OpenAlex
- W4416403131
- Cited by
- 3
- References
- 159
- Citations by year
- 2026: 3
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Australian Government
- University of New South Wales
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- CB2 receptor, CNR2, floxed allele, microglia, tamoxifen-inducible Cre, CX3CR1, TMEM119, off-target effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters. https://app.cochat.ai/papers/10.3389/fphar.2025.1682979
- The paper
- Laloli, K. J., Rentsch, P., Stayte, S., & Vissel, B. (2025). Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1682979
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.